Maeda Eiko, Okimura Hiroyuki, Tanaka Yukiko, Fujii Maya, Tarumi Yosuke, Kataoka Hisashi, Koshiba Akemi, Hamaguchi Masahide, Fukui Michiaki, Mori Taisuke, Kitawaki Jo
Department of Obstetrics and Gynecology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Hum Reprod. 2025 May 1;40(5):926-937. doi: 10.1093/humrep/deaf054.
Does the restoration of regulatory T cells (Tregs) suppress the progression of endometriosis?
Adoptive transfer of Tregs suppresses the progression of endometriosis and reduces the levels of helper T (Th)-cell-related and proinflammatory cytokines in mice.
Endometriosis is a chronic inflammatory gynecological disease, which involves multiple immune components. Activated Treg counts decrease in the endometrioma and endometrium of patients with endometriosis, and depletion of Tregs exacerbates endometriosis in mice.
STUDY DESIGN, SIZE, DURATION: We evaluated the effects of adoptive transfer of Tregs on the progression of endometriosis in mice. We used Foxp3tm3Ayr/J (Foxp3DTR) mice with temporarily ablated Tregs by injecting diphtheria toxin to develop an endometriosis model, which was generated by ovariectomy, estradiol administration and transplantation of uterine fragments from donor mice. Foxp3DTR mice were randomly divided into Treg adoptive transfer (n = 12) and control (n = 11) groups. Tregs were isolated from lymph nodes and spleens of wild-type (WT) mice and were adoptively transferred into mice that were temporarily Treg-depleted. Control mice were injected with vehicle. Treg adoptive transfer was performed on the day of uterine implantation, and a second adoptive transfer was performed after 14 days. Mice were euthanized 28 days after uterine implantation, and blood, peritoneal fluid, spleen, and endometriosis-like lesion samples were collected.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Foxp3DTR mice were intravenously injected with Tregs isolated from WT mice. The number, total weight, and total volume of the endometriosis-like lesions were evaluated on Day 28 following implantation of uterine fragments. The proportion of Tregs in endometriosis-like lesions, ascites, and peripheral blood was analyzed by flow cytometry. Inflammation in lesions and serum was examined using real-time PCR and ELISA.
Injection of Tregs increased their total count and decreased the number (P < 0.0001), weight (P = 0.0021), and volume (P = 0.0010) of endometriosis-like lesions in Foxp3DTR Treg-depleted mice. Furthermore, injection of Tregs decreased the mRNA expression of Th 1-, 2-, and 17-related cytokines, including interferon gamma (P = 0.0101), interleukin (IL)-4 (P = 0.0051), and IL-17 (P = 0.0177), as well as the levels of the proinflammatory cytokine IL-6 (P = 0.0002), in endometriosis-like lesions of Foxp3DTR Treg-depleted mice.
N/A.
LIMITATIONS, REASONS FOR CAUTION: Treg-related immune mechanisms in mice may not precisely reflect those in humans.
Restoration of Tregs may be a useful therapeutic strategy for inhibiting the progression of endometriosis in cases where the decrease in the Treg population is an exacerbating factor.
STUDY FUNDING/COMPETING INTEREST(S): This study was partially supported by the Grants-in-Aid for Scientific Research (grant numbers 18K16808 and 20K22983) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The sponsor had no role in the study design, collection, analysis and interpretation of data, writing of the report, and decision to submit the article for publication. The authors have no conflicts of interest to disclose.
调节性T细胞(Tregs)的恢复是否能抑制子宫内膜异位症的进展?
Tregs的过继转移可抑制子宫内膜异位症的进展,并降低小鼠体内辅助性T(Th)细胞相关细胞因子和促炎细胞因子的水平。
子宫内膜异位症是一种慢性炎症性妇科疾病,涉及多种免疫成分。子宫内膜异位症患者的子宫内膜瘤和子宫内膜中活化的Treg计数减少,Tregs的耗竭会加剧小鼠的子宫内膜异位症。
研究设计、规模、持续时间:我们评估了Tregs过继转移对小鼠子宫内膜异位症进展的影响。我们使用通过注射白喉毒素使Tregs暂时消融的Foxp3tm3Ayr/J(Foxp3DTR)小鼠建立子宫内膜异位症模型,该模型通过卵巢切除术、雌二醇给药以及移植供体小鼠的子宫片段产生。Foxp3DTR小鼠被随机分为Treg过继转移组(n = 12)和对照组(n = 11)。从野生型(WT)小鼠的淋巴结和脾脏中分离出Tregs,并过继转移到暂时Treg耗竭的小鼠体内。对照组小鼠注射赋形剂。在子宫植入当天进行Treg过继转移,并在14天后进行第二次过继转移。子宫植入后28天对小鼠实施安乐死,并收集血液、腹腔液、脾脏和子宫内膜异位症样病变样本。
参与者/材料、环境、方法:给Foxp3DTR小鼠静脉注射从WT小鼠分离出的Tregs。在植入子宫片段后的第28天评估子宫内膜异位症样病变的数量、总重量和总体积。通过流式细胞术分析子宫内膜异位症样病变、腹水和外周血中Tregs的比例。使用实时聚合酶链反应和酶联免疫吸附测定法检测病变和血清中的炎症情况。
注射Tregs增加了其总数,并减少了Foxp3DTR Treg耗竭小鼠中子宫内膜异位症样病变的数量(P < 0.0001)、重量(P = 0.0021)和体积(P = 0.0010)。此外,注射Tregs降低了Foxp3DTR Treg耗竭小鼠子宫内膜异位症样病变中Th1、Th2和Th17相关细胞因子的mRNA表达,包括干扰素γ(P = 0.0101)、白细胞介素(IL)-4(P = 0.0051)和IL-17(P = 0.0177),以及促炎细胞因子IL-6的水平(P = 0.0002)。
无。
局限性、谨慎理由:小鼠中与Treg相关的免疫机制可能无法精确反映人类的情况。
在Treg群体减少是一个加剧因素的情况下,恢复Tregs可能是抑制子宫内膜异位症进展的一种有用治疗策略。
研究资金/利益冲突:本研究部分得到了日本文部科学省科学研究资助金(资助编号18K16808和20K22983)的支持。资助者在研究设计、数据收集、分析和解释、报告撰写以及提交文章发表的决策过程中没有任何作用。作者没有利益冲突需要披露。